Tissue Biomarkers in Melanoma Patients Treated with TIL

While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on both progression-free survival and overall survival in patients with only one invaded lymph node (early stage III) compared to patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Knol, Anne-Chantal, Nguyen, Jean-Michel, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Brocard, Anabelle, Peuvrel, Lucie, Saint-Jean, Mélanie, Saiagh, Soraya, Khammari, Amir, Dréno, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527474/
https://www.ncbi.nlm.nih.gov/pubmed/23284620
http://dx.doi.org/10.1371/journal.pone.0048729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527474/
https://www.ncbi.nlm.nih.gov/pubmed/23284620
http://dx.doi.org/10.1371/journal.pone.0048729

Ejemplares similares